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Multidrug-resistant Staphylococcus aureus infections pose a signif-
icant threat to human health. Antibiotic resistance is most com-
monly propagated by conjugative plasmids like pLW1043, the ﬁrst
vancomycin-resistant S. aureus vector identiﬁed in humans. We
present the molecular basis for resistance transmission by the nick-
ing enzyme in S. aureus (NES), which is essential for conjugative
transfer. NES initiates and terminates the transfer of plasmids that
variously confer resistance to a range of drugs, including vanco-
mycin, gentamicin, and mupirocin. The NES N-terminal relaxase–
DNA complex crystal structure reveals unique protein–DNA con-
tacts essential in vitro and for conjugation in S. aureus. Using this
structural information, we designed a DNA minor groove-targeted
polyamide that inhibits NES with low micromolar efﬁcacy. The
crystal structure of the 341-residue C-terminal region outlines a
unique architecture; in vitro and cell-based studies further estab-
lish that it is essential for conjugation and regulates the activity of
the N-terminal relaxase. This conclusion is supported by a small-
angle X-ray scattering structure of a full-length, 665-residue NES–
DNA complex. Together, these data reveal the structural basis for
antibiotic multiresistance acquisition by S. aureus and suggest
novel strategies for therapeutic intervention.
MRSA | USA300 | F-plasmid | pSK41 | hairpin
Antibiotic resistance, which arises in bacterial pathogensthrough conjugative plasmid DNA transfer, is a well-estab-
lished threat to global health. For example, whereas vancomycin
has been essential in treating recalcitrant Staphylococcus aureus
infections for decades, vancomycin-resistant S. aureus (VRSA)
strains have now appeared in clinical settings worldwide (1–3).
VRSA ﬁrst arose in the United States through the interplay of
conjugative DNA transfer and resistance-determinant trans-
position. The resulting plasmid, pLW1043, has been sequenced
and contains not only a vanHAX vancomycin-resistance trans-
poson, but also a cadre of putative DNA transfer genes (4). It
was recently shown that the S. aureus plasmid pSK41, which is
closely related to pLW1043, mediates the transfer of vancomycin
resistance from Enterococcus faecalis into strains of methicillin
resistant S. aureus (MRSA) (5). Conjugative bacterial plasmids
use almost exclusively plasmid-encoded factors that work in
concert to coordinate the cell-to-cell transfer of one strand of
the duplex plasmid (6, 7). An element common to all conjugative
processes is the plasmid-encoded relaxase enzyme that initiates
and terminates transfer by creating a transient single-strand DNA
break and covalent protein–DNA intermediate (8, 9).
The vancomycin-resistance plasmid pLW1043 (4) and related
plasmids from S. aureus (10, 11), including pSK41 and pGO1
(12–14) as well as plasmids from streptococcal, lactococcal, and
clostridial strains, encode a relaxase enzyme termed nicking
enzyme in Staphylococcus (NES) that exhibits a unique full-
length sequence (Fig. S1). It is 665 residues in length, conﬁnes its
relaxase motifs to its N-terminal ∼220 aa, and encodes a “single
tyrosine”-type relaxase like MobA from plasmid R1162 (15),
although the NES and MobA relaxases share only 28% sequence
identity. NES is distinct from the second major class of conjugative
relaxases, like those from the F and R388 plasmids, which con-
tain more than one catalytic tyrosine (7). The C-terminal region
(residues 221–665) of NES is unique to pLW1043 and related S.
aureus plasmids, and its function has remained unclear. Most
plasmid relaxases are fused to catalytic C-terminal domains like a
primase (e.g., R1162) or helicase (e.g., F, R388) that are essential
to DNA transfer. In contrast, pLW1043’s NES C-terminal region
shares no sequence similarity with other bacterial proteins (13).
Here, we present crystal structures of the N- and C-terminal
domains of NES, as well as a small-angle X-ray scattering
(SAXS) structure of the full-length NES–DNA complex. We
show the two domains of NES work in concert to process DNA,
design a minor-groove targeted polyamide that inhibits NES at
low micromolar concentrations, and establish speciﬁc regions of
NES essential for plasmid transfer in S. aureus. Together, these
data unravel the molecular basis for antibiotic resistance acqui-
sition by S. aureus and suggest potential new avenues for dis-
rupting the spread of multidrug resistance.
Results
NES Crystal Structures. The pLW1043 nes gene was subcloned into
Escherichia coli expression vectors used to produce full-length, as
well as N-terminal and C-terminal forms of NES. The crystal
structure of the NES relaxase (residues 2–195) was determined
in complex with a 30-nt DNA sequence to 2.9 Å resolution (Fig.
1A and Table S1). The NES relaxase exhibits a structure similar
overall to that observed for the other conjugative relaxases re-
solved to date (sharing 2.2, 2.9, 3.1, and 3.1 Å Cα rmsd with
the MobA, F, R388, and pCU1 relaxases, respectively) (15–18)
and contains a metal ion coordinated by three histidines and an
adjacent catalytic tyrosine 25 (mutated to phenylalanine in this
structure) (Fig. 1A). Mass spectrometry data indicate that the
bound metal ion is nickel (Table S2), which is one of the ions
that we show supports NES relaxase activity in vitro (Fig. S2).
The bound DNA oligonucleotide contains a 7-bp duplex hairpin
followed by a 9-nt ordered single-stranded region that extends
into the relaxase’s active site.
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The crystal structure of the pLW1043 NES C-terminal domain
(residues 254–593) was determined to 3.0 Å resolution and
exhibits an all α-helical fold (α1–α16) with no structural homo-
logs identiﬁed using the Dali matrix-alignment method (Fig. 1B
and Table S1). Furthermore, it bears no structural similarity to
a helicase or a primase, like other relaxase-fused C-terminal do-
mains examined previously. Together these structures provide
unique atomic-level information on NES, an enzyme that drives
drug resistance propagation in S. aureus.
DNA Binding. Fluorescence anisotropy studies established that
DNA oligonucleotides ∼30 nt in length containing duplex hairpin
bound the NES relaxase domain with afﬁnities as low as 4 nM
(Tables S3 and S4). From this set, oligonucleotide oriTHP30
(30 nt, with the origin of transfer, “oriT”, and a hairpin, “HP”;
8 nM afﬁnity, Table S3) produced the cocrystal structure with the
NES relaxase outlined above (Fig. 1A). In the structure, 12 nt
contact 21 residues of the NES relaxase, forming 17 base-speciﬁc
interactions and 9 nonspeciﬁc phosphate interactions (Fig. 2A).
Of particular note, DNA hairpin-binding loop 1 (residues 78–82)
interacts with the DNA hairpin duplex minor groove and forms
two base-speciﬁc interactions and one phosphate contact (Fig.
2B). DNA hairpin-binding loop 2 works in concert with loop 1 to
close around the DNA duplex (Figs. 1A and 2A). Loop 2 (resi-
dues 150–156) binds to the major groove of the hairpin, forming
6 base-speciﬁc interactions and 4 phosphate contacts (Fig. 2C).
The single-stranded nine ordered nucleotides of the oriTHP30
oligonucleotide form 12 base-speciﬁc and 2 nonspeciﬁc phos-
phate interactions with the relaxase (Fig. 2D). The nucleotide
base of guanine 26 is buried in a cavity created by several res-
idues, including two making hydrogen-bonding contacts. Fluo-
rescence anisotropy polarization studies show that eliminating
this region of the oligonucleotide reduces relaxase binding by
20-fold (oriT27 vs. oriT24(-3); Table S3). Thus, NES employs
speciﬁc major- and minor-groove contacts around the DNA hair-
pin duplex, as well as backbone and unique base-speciﬁc inter-
actions, to align the DNA substrate for catalysis.
NES Catalysis. DNA cleavage assays using a 5′-6-FAM–labeled
substrate (oriTHP37; Table S4) revealed the NES relaxase
domain (residues 1–220) produces an equilibrium level of 15% (±
1%) cleaved DNA product (Fig. 3A), a value similar to that of
relaxases examined previously (18, 19). In contrast to the related
S. aureus pGO1 plasmid, which was reported to have a cleavage
site at GCC∧C (where ∧ indicates the putative nic site) (14), we
found that pLW1043 NES cleaves 2 nt upstream, at G∧CCC
(where residues in boldface type indicate the validated nic site;
Fig. S3 and Tables S3 and S4). NES relaxase mutants were then
designed to test the role that speciﬁc regions of the enzyme play in
catalytic function (Fig. 3A). An E86A substitution was found to
reduce the cleavage-religation equilibrium signiﬁcantly; in con-
trast, a K22A mutation increases cleavage-religation equilibrium,
whereas the addition of an adjacent charge (Ala-21-Glu) has no
impact on the enzyme (Fig. 3A). The K22A and A21E mutant
proteins show wild-type DNA binding; the E86A variant, however,
exhibits only nonspeciﬁc binding, indicating the important role
coordinated metal binding plays in substrate association (Table S5
and Fig. 2). K22 may interact with the DNA region downstream of
the cleavage site, as its mutation to an alanine produces an equi-
librium shift toward cleaved product (Fig. 3A; see also Fig. 2D).
The elimination of DNA-binding loop 1 or 2 exerted dramatic
impacts on NES activity. Removal of either of these regions
shifted the cleavage-religation equilibrium of the enzyme to ∼90%
cleaved DNA, close to trapping the enzyme in its covalent pro-
tein–DNA complex state (Fig. 3A). This occurs despite the fact
that the loop 1 or loop 2 deletion mutants exhibit either non-
speciﬁc or poor DNA binding relative to that in wild-type NES
(Table S5). Similarly, changes in speciﬁc DNA nucleotides also
shift the NES cleavage-religation equilibrium toward cleavage,
particularly the elimination of Gua-26 (Fig. 3B). Again, this
occurs despite the impact these changes have on DNA binding.
The shifts in cleavage-religation equilibrium are reminiscent of
speciﬁc topoisomerase mutants as well as topoisomerase-targeted
drugs that stabilize the covalent enzyme–DNA complex (20–22),
and they establish that loop 1, loop 2, and the Gua-26 binding
pocket play important roles in NES relaxase catalysis.
The isolated NES relaxase (residues 1–220) exhibited no DNA
cleavage until 4 nt were present past the nic site (oriTHP32; Fig.
3C). After that, the stepwise addition of nucleotides produced a
stepwise increase in 1–220 relaxase activity up to 35% product
formation (oriTHP33-45; Fig. 3C). Intriguingly, when the full-length
NES enzyme (1–665) was used, product equilibrium does not
exceed ∼10% regardless of the length of oligonucleotide assayed
(Fig. 3C). Thus, the presence of the C-terminal domain signiﬁ-
cantly impacts the catalytic activity of the N-terminal relaxase.
Furthermore, full-length NES is able to cleave DNA substrates
with only 2- to 3-nt 3′ extensions, in contrast to 1–220 NES (Fig.
Fig. 1. NES structure from S. aureus pLW1043. (A) Crystal structure of the
NES N-terminal relaxase (1–195) bound to a 30-nt oriT-containing hairpin
(OriTHP30). (B) Crystal structure of the C-terminal domain (254–593) with
domains highlighted in different shades of magenta.
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3C). Taken together, these data indicate that the unique C-ter-
minal domain of NES regulates the relaxase cleavage-religation
equilibrium of the intact enzyme.
SAXS Structure of Full-Length NES with DNA. Full-length NES alone
and in complex with oriTHP30DNA were examined by SAXS for
low-resolution structure determination. NES alone produced
SAXS data with clear concentration-dependent radius of gyra-
tion (Rg) values, indicating the formation of dynamic complexes
not amenable to interpretation. The complex of full-length NES
with DNA was well behaved, however, and gave a concentration-
independent 38-Å Rg in solution (Fig. S4 A and B). A dummy
atom bead model and associated molecular envelope of the
NES–DNA complex were calculated using MONSA (23) and
Chimera (24), respectively. These revealed the overall shape of
the complex (Fig. 3D, top, pink) and the location of the relatively
electron-rich DNA (Fig. 3D, top, yellow). SASREF (25) was
used for rigid-body ﬁtting of the structures of the N-terminal
relaxase–DNA complex and C-terminal domain crystal struc-
tures into this SAXS envelope. A solution was chosen that both
accommodated the SAXS envelope and placed the DNA of the
relaxase complex within the electron-rich region (Fig. 3D, top).
In addition, it positioned a positively charged region of the
C-terminal domain in close proximity to the DNA-bound NES
relaxase active site (Fig. 3D, bottom). Thus, this SAXS-based
structural model appears to corroborate the functional obser-
vation regarding the impact of the C-terminal domain on NES
relaxase activity (Fig. 3C). Together, they suggest a putative model
by which the C-terminal and N-terminal regions work in concert
to regulate the DNA cleavage-religation equilibrium of NES.
Regions Essential for DNA Transfer in S. aureus.Conjugative transfer
was examined in S. aureus, using the staphylococcal conjugative
plasmid family prototype pSK41 because its conjugative transfer
genes are nearly identical to pLW1043 but it lacks the dangerous
vancomycin-resistance transposon. Disruption of the nes gene
in pSK41 led to the elimination of plasmid transfer, as measured
by the number of DNA transfer events (the formation of
“transconjugants”) per donor S. aureus cell (Fig. 4A). This result
conﬁrms the essential role of NES in the transmission of pSK41
and related staphylococcal plasmids, including pLW1043 (14).
Importantly, whereas complementation with wild-type nes returns
conjugation to wild-type levels, complementation with speciﬁc
mutant nes genes designed on the basis of the NES crystal structures
dramatically impacted plasmid transfer (Fig. 4A). Variant nes genes
containing the deletion of either loop1 or loop2, both of which
signiﬁcantly disrupted the DNA cleavage-religation equilibrium of
NES in vitro (Figs. 2 and 3A), signiﬁcantly reduced conjugative
DNA transfer (Fig. 4A). Thus, the speciﬁc major- and minor-groove
DNA contacts formed by NES loops 1 and 2 are essential for
conjugative DNA transfer between S. aureus cells. Furthermore,
the C-terminal domain of NES is also required for conjugation.
Introduction of a stop codon after the nucleotides encoding
residue 303 in nes eliminated plasmid transfer in S. aureus (Fig. 4A).
This residue was chosen because the nes gene in the MRSA plasmid
pUSA03 is truncated at this position (26), as discussed below.
A B
C D
Fig. 2. DNA binding by S. aureus NES. (A) Schematic of the NES relaxase–DNA contacts with bases examined using variant oligos in boldface type. (B) Minor
groove-binding hairpin loop 1 of NES. (C) Major groove-binding hairpin loop 2 of NES. (D) Active site region of NES, with the buried Gua26 base highlighted.
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Taken together, these data establish that the loop 1 and 2 regions
of the NES relaxase domain, and the C-terminal domain of NES,
are required for the transfer of plasmids in S. aureus cells.
Polyamide Inhibition. The dependence of conjugative plasmid
transfer on an intact DNA-binding domain suggests the potential
for inhibiting relaxase function and limiting the spread of anti-
biotic resistance genes through disruption of NES–DNA interac-
tions. As a proof-of-concept, we examined the ability of synthetic
minor-groove binding ligands to inhibit NES activity. The GC-rich
hairpin sequence recognized by NES represents a low-afﬁnity target
for traditional minor-groove binding of natural products such as
distamycin and netropsin, which preferentially bind AT tracts
(27, 28). Indeed, in our hands we observed no signiﬁcant change in
NES relaxase activity when netropsin was added up to concen-
trations of 1 mM. This led us to investigate inhibition of NES by Py-
Im polyamides, a class of sequence-speciﬁc minor-groove binding
compounds that can be programmed to bind GC-rich sequences
with high afﬁnity (Fig. 4B) (29). Match polyamide 1 was designed to
bind selectively to the 5′-GCGAA-3′ sequence contacted by the
essential loop 1 of NES (Figs. 1Aand2B).As a control theactivity of
this compound was compared with that of a mismatch polyamide 2,
which shows lower afﬁnity for the 5′-GCGAA-3′ sequence (Fig. S5).
TheDNA cleavage activity of the relaxase 1–220 region ofNESwas
eliminated by match polyamide 1 at 50 μM (Fig. S6). Interestingly,
2.5- to 50-μM concentrations of the mismatch control polyamide 2
caused a signiﬁcant increase in product formation by the relaxase
(Fig. S6).This result is similar to thoseobtainedwhen the loop1and2
regions of the relaxase were deleted (Fig. 3A). Taken together, these
data indicate that, for the isolated relaxase domain, disrupting the
protein–DNA interactions around the DNA hairpin can signiﬁcantly
shift the enzyme’s cleavage-religation equilibrium. This effect, how-
ever, is not seen when intact, 1–665 NES is used, as outlined below.
With full-length NES, mismatch polyamide 2 showed no effect,
whereas the match polyamide 1 signiﬁcantly reduced DNA cleavage
activity at 25μM(Fig. 4C).Acloser examinationofNES inhibitionby
concentrations of polyamide 1 between 5 and 50 μM produced in-
hibition curves and IC50 values of 18 and 21 μM for the full-length
and relaxase regions ofNES, respectively (Fig. 4D). Thus, full-length
NES is inhibitedbyapolyamide targeted to thehairpinminor-groove
DNA sequence and is resistant to the effects of the nonspeciﬁc
polyamide. Taken together, these results conﬁrm that full-length
254
195
A B
DC
Fig. 3. Functional analysisofNES. (A)NESwild-type (WT)andvariant relaxaseactivities, including thatof loop1 (L1) and loop2 (L2)deletions. (B)ActivityofNES relaxase
with variant oligos, including an abasic G26 site. (C) Effect of DNA oligo length on NES relaxase and full-length activity. (D) Upper, SAXS envelope shape (pink) repre-
sentingaveragedandﬁltereddummyatommodelof theNES–DNAcomplex,with the relatively electron-rich region indicated (yellow) andNES crystal structuresdocked
by SUPCOMB. Lower, a positively charged region of the NES C-terminal domain is in proximity to the DNA-bound active site of the NES relaxase in the docked model.
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NES acts in a manner distinct from that of the isolated relaxase with
respect to catalytic activity and suggest thatwith furtherdevelopment
small molecules capable of inhibiting NES–DNA interactions could
disrupt NES function to prevent antibiotic resistance transfer.
Discussion
Antibiotic resistance propagation is largely mediated by the
conjugative DNA transfer of plasmids encoding resistance genes,
as well as nearly all of the factors required for DNA transmission
from donor to recipient cells (7, 9, 30). We focused on the NES
relaxase enzyme from plasmid pLW1043, the ﬁrst vancomycin-
resistance vector identiﬁed in S. aureus (4). pLW1043 and related
plasmids like pSK41 variously harbor resistance to key antibiotics
like vancomycin, aminoglycosides, β-lactams, and mupirocin (6).
The NES relaxase was shown to contain two essential loops (1, 2)
that close around the bound DNA hairpin (Figs. 1A and 2). We
establish that the disruption of these loops, using either muta-
genesis or a polyamide, inhibits NES activity in vitro (Figs. 3A
and 4 B–D). Furthermore, the deletion of either of these loops
eliminates plasmid DNA transfer in S. aureus (Fig. 4A).
Minor-groove–targeted Py-Im Polyamide 1, designed to bind
to the GC-rich DNA minor groove of the NES substrate hair-
pin, demonstrated IC50 values of 20 μM with respect to DNA
cleavage. Although optimization of polyamide architecture and
functionalization will be necessary to promote organism-spe-
ciﬁc uptake in S. aureus, these results suggest a future approach
for targeted disruption of antibiotic resistance transfer. Minor-
groove binders similar to Py-Im polyamides have shown activity
against S. aureus in vitro and in animal models of infection (31,
32). Interestingly, there is a natural precedent for targeting NES
activity as a means to limit DNA transfer, in the form of a func-
tional CRISPR containing a nes-speciﬁc spacer that is present in
the genome of Staphylococcus epidermidis strain RP62a (33).
This is a unique single-tyrosine relaxase structure resolved in
complex with DNA, and DNA binding by NES is clearly distinct
relative to the “multityrosine” relaxase–DNA complex structures
elucidated previously. The cavity that holds the buried Gua-26
nucleotide base in NES is conserved in the single-tyrosine
relaxase structure of plasmid R1162 MobA determined without
DNA (Fig. S7A and Fig. 2D) (15). In contrast, the multityrosine
B
D
A
C
Fig. 4. NES in S. aureus and polyamide inhibition. (A) Effect of nes deletion (KO) and complementation with WT and designed NES loop 1 (L1), loop 2 (L2),
and C-terminal deletion (ΔC-term) mutants on conjugation in S. aureus. (B) Structures of the Match Polyamide 1 and Mismatch Polyamide 2. (C) Inhibition of
full-length NES with Match 1 (solid bars) and Mismatch 2 (shaded bars) polyamides. (D) Eighteen- and 21-μM IC50 values of the Match Polyamide 1 for the full-
length and relaxase forms of NES, respectively.
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relaxases from plasmids pCU1, R388, and F all position a helix in
place of the short loop in NES (Fig. S7 B–D) (16–18), and these
helices occlude the Gua-26 binding pocket. Thus, whereas the
multityrosine relaxases use a “thumb” region not present in NES
or MobA (Fig. S7 C and D), the shorter single-tyrosine relaxases
likely rely on burying a nucleotide adjacent to its active site to
align the substrate DNA. Recall that deletion of Gua-26 signiﬁ-
cantly impacted the equilibrium cleavage activity of NES (Fig. 3B).
These data suggest the Gua-26 binding pocket in NES-like relaxases
may be targeted in future studies to disrupt enzyme activity.
The structural and biochemical data presented here, together
with in vivo observation that the deletion of the NES C-terminal
domain signiﬁcantly reduces conjugation, suggest that the C-
terminal domain regulates the NES processing of the DNA sub-
strate during conjugative transfer. The 11 deposited S. aureus nes
genes are identical in amino acid sequence within their conserved
N-terminal relaxase domains (residues 1–220). In addition, 7 en-
code 665-residue proteins with complete C-terminal domains. In
contrast, 4 exhibit signiﬁcantly shorter C-terminal regions, in-
cluding one truncated at residue 555 (accession no. EIK19451)
and another that ends at position 482 (ADM29113) (34) (Fig. S8).
The 2 remaining sequenced S. aureus nes genes have severely
limited C-terminal domains, terminating their coding regions at
residues 300 or 303 (CCJ09841, YP_492718) (Fig. S8). The 303-
residue NES (YP_492718) is produced by a frameshift in the nes
gene on plasmid pUSA03 in some USA300 strains of MRSA (26).
The truncated NES we used was created to mimic this 303-residue
protein. Our ﬁnding that the C-terminal 362 residues of NES were
required for efﬁcient conjugation strongly suggests that pUSA03
plasmids with truncated nes genes would be unable to conjugate on
their own and may require factors present on coresident plasmids.
Methods
Crystal Structure Determination. Puriﬁed NES constructs were crystallized
using hanging drop vapor diffusion, and data for the relaxase–DNA complex
and the C-terminal domain, respectively (Table S1), were collected at the
National Institute of General Medical Sciences and National Cancer Institute
Collaborative Access Team (GM/CA-CAT). Structures were determined and
reﬁned using Phenix and manually adjusted with Coot (SI Methods).
DNA-Binding Studies. Direct binding to relaxase and full-length constructs
were measured using ﬂuorescence polarization anisotropy and a 6FAM-
oriT31 (Table S3). Competition binding studies used ﬂuorescence polariza-
tion anisotropy and titrations of unlabeled DNA (SI Methods).
DNA Cleavage Assays. Equilibrium DNA cleavage was examined using 6FAM-
labeled oligos with product formation monitored on PAGE gels. Percentage
of product formation was quantiﬁed using samples in triplicate (SI Methods).
Small-Angle X-ray Scattering. Full-length NES was examined in complex with
oriTHP30 DNA, using SAXS on a Rigaku Bio-SAXS 1000 instrument with 60-
min collection scans at three concentrations. Concentration-independent
Rg values were obtained, and averaged and ﬁltered dummy atom models
were created and used for docking (25) (SI Methods).
Conjugation Assays in S. Aureus. An nes gene knockout S. aureus strain was
generated using the Lactococcus lactis Ll.LtrB group II intron (35). WT and
mutant nes complementation plasmids were generated in pSK5632 in which
nes transcription was driven by a lac promoter (36). Matings were performed
on solid surfaces for 20 h, followed by cell recovery and plating with anti-
biotic selection to determine conjugation frequency (SI Methods).
Polyamide Inhibition Studies. Polyamides were synthesized and characterized,
and their effects on full-length and relaxase domain NES constructs were
determined as described in SI Methods.
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